In this context, the authors suggest that since most of the highlighted cytokines stimulate neuronal damage, tau, and Aβ pathology, as well as breakdown of the blood–brain barrier, neuro-inflammation may modulate the effects of diabetes on the pathogenesis of AD. The gene discussed is MAPT; the disease is diabetes mellitus.